mifepristone has been researched along with Abortion, Missed in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (34.62) | 18.2507 |
2000's | 9 (34.62) | 29.6817 |
2010's | 3 (11.54) | 24.3611 |
2020's | 5 (19.23) | 2.80 |
Authors | Studies |
---|---|
Bettencourt-Silva, B; Brás, F; Cunha, AI; Furtado, JM; Lopes-Guerra, C; Miguelote, R; Miranda, C; Rego, MT; Sousa-Santos, R | 1 |
Altman, D; Ehrnstén, L; Kopp Kallner, H; Ljungblad, A | 1 |
Kleiverda, G; Leusink, P | 1 |
Ahmed, A; Beeson, LE; Bender-Atik, R; Bhatia, K; Bottomley, C; Brewin, J; Cheed, V; Cheong, Y; Choudhary, M; Chu, JJ; Coomarasamy, A; Debs, S; Devall, AJ; Gallos, ID; Gupta, P; Hamilton, J; Hardy, P; Hassan, I; Hinshaw, K; Hodge, FS; Horne, AW; Izzat, F; Jeve, Y; Jones, LL; Kumar, CS; La Fontaine Papadopoulos, JH; Naftalin, J; Nunes, N; Okeke Ogwulu, CB; Oliver, A; Pringle, S; Quenby, S; Roberts, TE; Ross, J; Shahid, A; Small, R; Underwood, M; Watkins, L; Williams, EV; Yongzhong, S | 1 |
Beeson, LE; Coomarasamy, A; Devall, AJ; Do, V; Gallos, ID; Ghosh, J; Gülmezoglu, AM; Jeffery, HC; Lavelanet, A; Papadopoulou, A; Price, MJ; Tobias, A; Tunçalp, Ö | 1 |
Kovač, V; Reljič, M; Serdinšek, T | 1 |
Banerjee, AK; Emembolu, JO; Habiba, M | 1 |
Ben-Meir, A; Erez, Y; Feigenberg, T; Hamani, Y; Laufer, N; Rojansky, N | 1 |
Brouns, JF; Burger, MP; van Wijngaarden, WJ | 1 |
Andersen, B; Clevin, L; Grønlund, A; Grønlund, L; Lidegaard, Ø; Palmgren, N | 1 |
Chia, KV; Ogbo, VI | 1 |
Coughlin, LB; Haddad, NG; Long, A; Roberts, D | 1 |
Ashok, PW; Flett, GM; Hamoda, H; Templeton, A | 1 |
Dulitzky, M; Goldenberg, M; Machtinger, R; Schiff, E; Seidman, DS; Soriano, D; Stockheim, D; Wiser, A | 1 |
Chen, BA; Creinin, MD | 1 |
Bygdeman, M | 1 |
Baton-Saint-Mleux, C; Bourget, P; Fernandez, H; Frydman, R; Lelaidier, C | 1 |
Hahlin, M; Nielsen, S; Platz-Christensen, JJ | 1 |
Jurkovic, D | 1 |
El-Refaey, H; Templeton, A | 1 |
Cheng, L; Gao, PP; Ho, PC; Lee, SW; Tang, OS | 1 |
Darney, PD; Goldberg, AB; Greenberg, MB | 1 |
Child, TJ; MacKenzie, IZ; Rees, M | 1 |
el-Refaey, H; Henshaw, R; Hinshaw, K; Smith, N; Templeton, A | 1 |
Grall, F; Sylvestre, L | 1 |
Asch, RH; Balmaceda, JP; Rojas, F; Spitz, IM; Tadir, Y; Weckstein, LN | 1 |
4 review(s) available for mifepristone and Abortion, Missed
Article | Year |
---|---|
Methods for managing miscarriage: a network meta-analysis.
Topics: Abortion, Incomplete; Abortion, Missed; Abortion, Spontaneous; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Network Meta-Analysis; Oxytocics; Placebos; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic; Suction; Vacuum Curettage; Watchful Waiting | 2021 |
Contemporary management of early pregnancy failure.
Topics: Abortifacient Agents; Abortion, Missed; Combined Modality Therapy; Dilatation and Curettage; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Vacuum Extraction, Obstetrical | 2007 |
Modern management of miscarriage: is there a place for non-surgical treatment?
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Missed; Abortion, Spontaneous; Dilatation and Curettage; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1998 |
Misoprostol and pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Abortion, Missed; Cervical Ripening; Drug Therapy, Combination; Empirical Research; Female; Government Regulation; Humans; Labor, Induced; Methotrexate; Mifepristone; Misoprostol; Mobius Syndrome; Oxytocics; Postpartum Hemorrhage; Pregnancy; Pregnant Women | 2001 |
10 trial(s) available for mifepristone and Abortion, Missed
Article | Year |
---|---|
The role of mifepristone on first trimester miscarriage treatment - A double-blind randomized controlled trial - MiFirsT.
Topics: Abortion, Missed; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2023 |
Cost-effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trial.
Topics: Abortifacient Agents; Abortion, Missed; Adolescent; Adult; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Young Adult | 2021 |
Mifepristone followed by high-dose oxytocin drip for second-trimester abortion: a randomized, double-blind, placebo-controlled, pilot study.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Missed; Administration, Oral; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Mifepristone; Oxytocin; Pilot Projects; Placebos; Pregnancy; Pregnancy Trimester, Second; Young Adult | 2009 |
Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
Topics: Abortifacient Agents; Abortion, Missed; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Chorionic Gonadotropin; Cross-Over Studies; Denmark; Drug Administration Schedule; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Treatment Outcome | 2002 |
Medical termination of missed abortion.
Topics: Abortifacient Agents; Abortion, Missed; Abortion, Therapeutic; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Pregnancy; Treatment Outcome; Ultrasonography; Vacuum Curettage | 2002 |
A randomized prospective study of misoprostol or mifepristone followed by misoprostol when needed for the treatment of women with early pregnancy failure.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Missed; Adult; Drug Combinations; Female; Hormone Antagonists; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Outcome; Treatment Outcome | 2006 |
Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial.
Topics: Abortion, Missed; Adult; Double-Blind Method; Female; Humans; Mifepristone; Placebos; Pregnancy; Prospective Studies; Uterine Hemorrhage | 1993 |
Unsuccessful treatment of missed abortion with a combination of an antiprogesterone and a prostaglandin E1 analogue.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Missed; Administration, Oral; Drug Combinations; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Treatment Failure | 1997 |
A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Missed; Adult; Contraceptives, Oral; Double-Blind Method; Female; Hemoglobins; Humans; Mifepristone; Misoprostol; Placebos; Pregnancy; Time Factors; Uterine Hemorrhage | 1999 |
[Use of mifepristone (RU 486) in pregnancy (excluding abortion on demand). The first clinical trials].
Topics: Abortion, Missed; Abortion, Therapeutic; Adult; Clinical Protocols; Female; Fetal Death; Humans; Mifepristone; Pregnancy; Treatment Outcome; Ultrasonography | 1991 |
12 other study(ies) available for mifepristone and Abortion, Missed
Article | Year |
---|---|
Efficacy of mifepristone and misoprostol for medical treatment of missed miscarriage in clinical practice-A cohort study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Missed; Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Organ Size; Pregnancy; Pregnancy Trimesters; Treatment Outcome; Ultrasonography; Uterus; Young Adult | 2020 |
[Mifepristone in primary care: no impediments against its use in management of missed miscarriage].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Legal; Abortion, Missed; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Netherlands; Pilot Projects; Pregnancy; Primary Health Care | 2021 |
Medical management of first trimester missed miscarriage: the efficacy and complication rate.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Missed; Adolescent; Adult; Chorionic Gonadotropin, beta Subunit, Human; Curettage; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Uterine Hemorrhage; Young Adult | 2019 |
The association between serum progesterone and outcome of medical management of early fetal demise: a pilot study.
Topics: Abortifacient Agents; Abortion, Missed; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Progesterone; Prospective Studies; Treatment Failure; Young Adult | 2013 |
Evaluation of the introduction of a new treatment for the termination of pregnancy in The Netherlands.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Missed; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gynecology; Humans; Mifepristone; Misoprostol; Netherlands; Obstetrics; Off-Label Use; Practice Patterns, Physicians'; Pregnancy; Pregnancy Trimesters; Premedication; Surveys and Questionnaires; Vacuum Curettage | 2010 |
Medical management of first trimester miscarriage (blighted ovum and missed abortion): is it effective?
Topics: Abortion, Missed; Abortion, Spontaneous; Administration, Oral; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endosonography; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Risk Assessment; Treatment Outcome | 2004 |
Medical abortion at 9-13 weeks' gestation: a review of 1076 consecutive cases.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Missed; Administration, Intravaginal; Adult; Drug Administration Schedule; Drug Combinations; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Retrospective Studies | 2005 |
[Treatment in miscarriage and abortion. Widened use of drugs has many advantages].
Topics: Abortion, Missed; Abortion, Spontaneous; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Receptors, Progesterone | 1994 |
Unsuccessful treatment of missed abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Missed; Female; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Uterine Hemorrhage | 1998 |
Curettage after mifepristone-induced abortion: frequency, timing, and indications.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Missed; Dilatation and Curettage; Female; Humans; Mifepristone; Parity; Pregnancy | 2001 |
Medical management of missed abortion and anembryonic pregnancy.
Topics: Abortion, Induced; Abortion, Missed; Administration, Oral; Adult; Female; Humans; Mifepristone; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First | 1992 |
Non-surgical expulsion of non-viable early pregnancy: a new application of RU 486.
Topics: Abortion, Missed; Adult; Female; Humans; Mifepristone; Pregnancy | 1990 |